Leading pharmaceuticals and biotechs, plus a few industrial companies and a long list of inventors, told the House and Senate Judiciary committees Monday that the PTO is doing the right thing by deferring to rocket docket district court litigation.
October 26, 2020 at 06:53 PM
1 minute read
A long list of biotech and pharmaceutical companies, industrials, universities and individual inventors have written to House and Senate Judiciary committee leaders, asking them to support the U.S. Patent and Trademark Office’s efforts to trim back administrative patent validity challenges in deference to rocket docket district court litigation.
Deal Watch: Skadden, Sidley, Slaughter and S&C Lead Big Paper Deal, While Private Funds Grow Massive
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
Johnson & Johnson, Raytheon, Merck and 3M (Photos: Shutterstock.com)
